Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AcTau174: A New CSF Biomarker for FTLD-TDP Diagnosis and Progression

Summary by Archyde
Archyde Published this week in Nature Medicine, researchers have identified AcTau174, a new cerebrospinal fluid (CSF) biomarker that distinguishes between TDP-43 and tau protein pathologies in patients with frontotemporal lobar degeneration ... Read More The post AcTau174: A New CSF Biomarker for FTLD-TDP Diagnosis and Progression appeared first on Archyde.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

archydearchyde

AcTau174: A New CSF Biomarker for FTLD-TDP Diagnosis and Progression

Archyde Published this week in Nature Medicine, researchers have identified AcTau174, a new cerebrospinal fluid (CSF) biomarker that distinguishes between TDP-43 and tau protein pathologies in patients with frontotemporal lobar degeneration ... Read More The post AcTau174: A New CSF Biomarker for FTLD-TDP Diagnosis and Progression appeared first on Archyde.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

archyde broke the news on Wednesday, April 15, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

TDP icon

TDP

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal